VERZENIO FILM-COATED TABLET 100MG Singapore - English - HSA (Health Sciences Authority)

verzenio film-coated tablet 100mg

dksh singapore pte. ltd. - abemaciclib - tablet, film coated - abemaciclib 100.0mg

VERZENIO FILM-COATED TABLET 150MG Singapore - English - HSA (Health Sciences Authority)

verzenio film-coated tablet 150mg

dksh singapore pte. ltd. - abemaciclib - tablet, film coated - abemaciclib 150.0mg

VERZENIO FILM-COATED TABLET 50MG Singapore - English - HSA (Health Sciences Authority)

verzenio film-coated tablet 50mg

dksh singapore pte. ltd. - abemaciclib - tablet, film coated - abemaciclib 50.00mg

YULAREB FILM-COATED TABLET 100MG Singapore - English - HSA (Health Sciences Authority)

yulareb film-coated tablet 100mg

dksh singapore pte. ltd. - abemaciclib - tablet, film coated - abemaciclib 100.0mg

YULAREB FILM-COATED TABLET 150MG Singapore - English - HSA (Health Sciences Authority)

yulareb film-coated tablet 150mg

dksh singapore pte. ltd. - abemaciclib - tablet, film coated - abemaciclib 150.0mg

YULAREB FILM-COATED TABLET 50MG Singapore - English - HSA (Health Sciences Authority)

yulareb film-coated tablet 50mg

dksh singapore pte. ltd. - abemaciclib - tablet, film coated - abemaciclib 50mg

Verzenios European Union - English - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - breast neoplasms - antineoplastic agents - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5.1).in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist.advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy.in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

VERZENIO TABLET Canada - English - Health Canada

verzenio tablet

eli lilly canada inc - abemaciclib - tablet - 50mg - abemaciclib 50mg - antineoplastic agents

VERZENIO TABLET Canada - English - Health Canada

verzenio tablet

eli lilly canada inc - abemaciclib - tablet - 100mg - abemaciclib 100mg - antineoplastic agents

VERZENIO TABLET Canada - English - Health Canada

verzenio tablet

eli lilly canada inc - abemaciclib - tablet - 150mg - abemaciclib 150mg - antineoplastic agents